• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评价心血管疾病治疗潜在危害的偏好:一项社区成年居民的调查。

Rating the preferences for potential harms of treatments for cardiovascular disease: a survey of community-dwelling adults.

机构信息

Biostatistics and Data Management Core, University of Hawaii John A. Burns School of Medicine, Honolulu, Hawaii (GXZ)

Departments of Medicine (Cardiology) (PBP, DLB)

出版信息

Med Decis Making. 2013 May;33(4):502-9. doi: 10.1177/0272989X13475717. Epub 2013 Feb 13.

DOI:10.1177/0272989X13475717
PMID:23407665
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3749300/
Abstract

BACKGROUND

The Institute of Medicine has called for a new health care paradigm that integrates patient values into discussions of the risks and benefits of treatment. Although cardiovascular disease (CVD) affects one-third of Americans, little is known about how adults regard the potential harms or complications of treatment.

OBJECTIVE

We sought to determine the preferences of community-dwelling adults for 15 potential harms or complications resulting from treatment of CVD.

METHODS

In a telephone survey, adults older than 18 years residing on Long Island, New York, were asked to score the preferences for 15 potential harms or complications of treatment of CVD on a scale from 0 to 100. All statistical analyses were based on nonparametric methods. Multivariable general linear model analyses were performed to identify demographic factors associated with the score assigned for each adverse outcome.

RESULTS

The 807 individuals surveyed generated 723 unique sequences of scores for the 15 outcomes. The ranking of scores from least to most acceptable was stroke, major myocardial infarction (MI), cognitive dysfunction, renal failure, death, prolonged ventilator support, heart failure, angina, sternal wound infection, major bleeding, reoperation, prolonged recovery in a nursing home, cardiac readmission, minor MI, and percutaneous coronary intervention. Demographic factors accounted for less than 7% of the observed variation in the score attributed to each outcome.

CONCLUSIONS

Individual community-dwelling adults living on Long Island, New York, assign unique values to their preferences for potential harms encountered following treatment of CVD. Thus, risk-benefit discussions and treatment decisions regarding CVD should be harmonized to the value system of each individual.

摘要

背景

美国国家医学研究院呼吁建立一种新的医疗保健模式,将患者的价值观纳入治疗风险和益处的讨论中。尽管心血管疾病(CVD)影响了三分之一的美国人,但对于成年人如何看待治疗的潜在危害或并发症知之甚少。

目的

我们旨在确定社区居住的成年人对 CVD 治疗可能产生的 15 种潜在危害或并发症的偏好。

方法

在一项电话调查中,要求居住在纽约长岛的 18 岁以上成年人在 0 到 100 的评分范围内对 CVD 治疗的 15 种潜在危害或并发症的偏好进行评分。所有统计分析均基于非参数方法。采用多变量一般线性模型分析来确定与每种不良结局评分相关的人口统计学因素。

结果

接受调查的 807 人共生成了 15 种不良结局的 723 个独特评分序列。从最不可接受到最可接受的评分排名是中风、大面积心肌梗死(MI)、认知功能障碍、肾衰竭、死亡、延长呼吸机支持、心力衰竭、心绞痛、胸骨伤口感染、大出血、再次手术、在疗养院延长康复、心脏再入院、轻度 MI 和经皮冠状动脉介入治疗。人口统计学因素仅占每个结局评分归因于每个结局的观察变异的 7%以下。

结论

生活在纽约长岛的社区居民个体对 CVD 治疗后可能遇到的潜在危害赋予了独特的价值。因此,CVD 的风险-效益讨论和治疗决策应与每个人的价值体系相协调。

相似文献

1
Rating the preferences for potential harms of treatments for cardiovascular disease: a survey of community-dwelling adults.评价心血管疾病治疗潜在危害的偏好:一项社区成年居民的调查。
Med Decis Making. 2013 May;33(4):502-9. doi: 10.1177/0272989X13475717. Epub 2013 Feb 13.
2
Incorporating patient preferences into clinical trial design: results of the opinions of patients on treatment implications of new studies (OPTIONS) project.将患者偏好纳入临床试验设计:患者对新研究治疗影响的意见(OPTIONS)项目结果
Am Heart J. 2015 Jan;169(1):122-31.e22. doi: 10.1016/j.ahj.2014.10.002. Epub 2014 Oct 13.
3
4
5
6
Shared decision-making about cardiovascular disease medication in older people: a qualitative study of patient experiences in general practice.老年人心血管疾病药物治疗的共同决策:一般实践中患者体验的定性研究。
BMJ Open. 2019 Mar 20;9(3):e026342. doi: 10.1136/bmjopen-2018-026342.
7
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
8
9
10

引用本文的文献

1
Expanding the use and interpretation of patient-centric cardiovascular clinical trial endpoints.扩大以患者为中心的心血管临床试验终点的应用和解读。
J Clin Transl Sci. 2025 Jul 3;9(1):e151. doi: 10.1017/cts.2025.10054. eCollection 2025.
2
Age, knowledge, preferences, and risk tolerance for invasive cardiac care.年龄、知识、偏好和对侵入性心脏治疗的风险承受能力。
Am Heart J. 2020 Jan;219:99-108. doi: 10.1016/j.ahj.2019.09.008. Epub 2019 Oct 23.
3
General Population vs. Patient Preferences in Anticoagulant Therapy: A Discrete Choice Experiment.一般人群与抗凝治疗患者偏好的差异:一项离散选择实验。
Patient. 2019 Apr;12(2):235-246. doi: 10.1007/s40271-018-0329-1.

本文引用的文献

1
Heart disease and stroke statistics--2012 update: a report from the American Heart Association.《2012年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2012 Jan 3;125(1):e2-e220. doi: 10.1161/CIR.0b013e31823ac046. Epub 2011 Dec 15.
2
Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery.药物洗脱支架置入术或冠状动脉旁路移植术后的生活质量。
N Engl J Med. 2011 Mar 17;364(11):1016-26. doi: 10.1056/NEJMoa1001508.
3
Informed consent in clinical care: practical considerations in the effort to achieve ethical goals.临床护理中的知情同意:实现伦理目标过程中的实际考量
JAMA. 2011 Mar 16;305(11):1130-1. doi: 10.1001/jama.2011.333.
4
Effects of benefits and harms on older persons' willingness to take medication for primary cardiovascular prevention.益处和危害对老年人进行原发性心血管预防用药意愿的影响。
Arch Intern Med. 2011 May 23;171(10):923-8. doi: 10.1001/archinternmed.2011.32. Epub 2011 Feb 28.
5
Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation.推动临界点:房颤患者抗凝治疗的决策
Circ Cardiovasc Qual Outcomes. 2011 Jan 1;4(1):14-21. doi: 10.1161/CIRCOUTCOMES.110.958108. Epub 2010 Dec 7.
6
Medical decision making: how patients choose.医疗决策:患者如何做出选择。
Med Decis Making. 2010 Sep-Oct;30(5 Suppl):8S-10S. doi: 10.1177/0272989X10381090.
7
Measurement of post-operative cognitive dysfunction after cardiac surgery: a systematic review.心脏手术后认知功能障碍的测量:一项系统综述
Acta Anaesthesiol Scand. 2010 Jul;54(6):663-77. doi: 10.1111/j.1399-6576.2010.02236.x. Epub 2010 Apr 15.
8
Trial and error. How to avoid commonly encountered limitations of published clinical trials.反复尝试。如何避免常见的已发表临床试验的局限性。
J Am Coll Cardiol. 2010 Feb 2;55(5):415-27. doi: 10.1016/j.jacc.2009.06.065.
9
Composite end points in randomized trials: there is no free lunch.随机试验中的复合终点:没有免费的午餐。
JAMA. 2010 Jan 20;303(3):267-8. doi: 10.1001/jama.2009.2017.
10
Sharing decision making about cardiac surgery: improving the quality of the decision to undergo or forego surgery.心脏手术的共同决策:提高接受或放弃手术决策的质量。
Circ Cardiovasc Qual Outcomes. 2009 Nov;2(6):519-21. doi: 10.1161/CIRCOUTCOMES.109.912246.